Matching slides 26,550
Current window 19,741-19,770
Pages 885
Rows per page 30
Arc: Problem Agitate Solutionclear collectionreset all

Arc

19,741-19,770 of 26,550

filter-aware
06
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Problem Statement1 hit
08
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Key Messages1 hit
10
The slide uses a narrative structure to outline the patient's clinical progression from birth to genetic diagnosis.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Patient Medical History1 hit
11
The slide uses a timeline framework to map clinical events against age in years.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Patient Medical History1 hit
13
The slide uses a before-after framework to demonstrate the efficacy of the treatment plan.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Diagnostic Methods and Biochemistry Labs1 hit
16
Aeglea BioTherapeutics | Investor Presentation Deck | 33 slidesAeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Summary and Conclusions1 hit
21
The chart is a box plot showing arginine levels over time, with reference lines for normal and target ranges.Aeglea BioTherapeutics | Investor Presentation Deck | 33 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Pegzilarginase Program OverviewLoop · Jobs To Be Done1 hit
06
The diagram uses a circular flow to categorize drug mechanisms (Immune engagers, Cell therapy, Oncolytic virus, Immuno-oncology, DNA damage response, Antibody drug conjugates, Radioimmuno-conjugates, Nanomedicines, Epigenetics).AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Interest1 hit
07
The slide categorizes the 19 abstracts into oral, mini-oral, and poster presentations, and lists three specific clinical trial highlights.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Interest1 hit
21
The slide features a stylized silhouette of a human figure with internal biological/molecular imagery.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
25
The slide uses a flow-chart style diagram to segment the patient population and position the Lynparza + abiraterone combination.AstraZeneca | Investor Day Presentation Deck | 35 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
01
Slide 1
BioNTech | Investor Day Presentation Deck | 15 slidesBioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
02
BioNTech | Investor Day Presentation Deck | 15 slidesBioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
03
BioNTech | Investor Day Presentation Deck | 15 slidesBioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
04
The slide uses a three-column layout to categorize facility functions.BioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
BioNTech | Investor Day Presentation Deck | 15 slidesBioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
06
The slide uses a table to detail the modular setup, logistics, and production capabilities of the BioNTainer system.BioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
07
The slide uses a process flow diagram to explain the manufacturing modularity.BioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
08
BioNTech | Investor Day Presentation Deck | 15 slidesBioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
09
BioNTech | Investor Day Presentation Deck | 15 slidesBioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
10
Uses a before-after-bridge framework to contrast the complexity of GMP production with a modular, turnkey solution.BioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
11
The slide uses a 4-column layout where each column pairs a strategic pillar with a supporting quantitative metric.BioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Before After1 hit
14
The slide uses a process-oriented layout with a primary milestone followed by four subsequent operational steps.BioNTech | Investor Day Presentation Deck | 15 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
64
WPT is represented by the black bars in both charts, showing the lowest P/FFO and highest Cap Rate.Blackwells Capital | Activist Presentation Deck | 207 slides · Blackwells Capital
Activist deck Activist investor Beat · ProblemLoop · Cost Of Inaction1 hit
65
Blackwells Capital | Activist Presentation Deck | 207 slidesBlackwells Capital | Activist Presentation Deck | 207 slides · Blackwells Capital
Activist deck Activist investor Beat · Agitate1 hit
66
Uses a 'FAIL' stamp visual to emphasize the critique of the board.Blackwells Capital | Activist Presentation Deck | 207 slides · Blackwells Capital
Activist deck Activist investor Beat · Agitate1 hit
67
Used to argue for misalignment between board and shareholders.Blackwells Capital | Activist Presentation Deck | 207 slides · Blackwells Capital
Activist deck Activist investor Beat · Agitate1 hit
75
Blackwells Capital | Activist Presentation Deck | 207 slidesBlackwells Capital | Activist Presentation Deck | 207 slides · Blackwells Capital
Activist deck Activist investor Beat · SolutionLoop · Quick Win Big Bet1 hit
76
The slide uses a two-part structure: Business Highlights (observations) and Opportunities (strategic action).Blackwells Capital | Activist Presentation Deck | 207 slides · Blackwells Capital
Activist deck Activist investor Beat · SolutionLoop · Quick Win Big Bet1 hit
77
Uses a simple process-oriented list structure to define the activist strategy.Blackwells Capital | Activist Presentation Deck | 207 slides · Blackwells Capital
Activist deck Activist investor Beat · SolutionLoop · Quick Win Big Bet1 hit